Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Effect of the MyDéfi Smartphone Application on Binge Drinking Among University Students: Protocol of a Double‐Blind Multicenter Prospective National Randomized Controlled Trial Using Phosphatidylethanol as a Biomarker—The SMARTBINGE Trial

Title: Effect of the MyDéfi Smartphone Application on Binge Drinking Among University Students: Protocol of a Double‐Blind Multicenter Prospective National Randomized Controlled Trial Using Phosphatidylethanol as a Biomarker—The SMARTBINGE Trial
Authors: André, Camille; Sauton, Pierre; Dreinaza, Méléna; Diouf, Momar; Bodeau, Sandra; Martinetti, Margaret; Trouillet, Raphaël; De Groote, Clara; Nandrino, Jean-Louis; Alexandre, Adèle; Benzerouk, Farid; Gierski, Fabien; Perney, Pascal; Grellet, Laure; André, Judith; Naassila, Mickael
Contributors: Université de Lille; CNRS; CHU Lille; Groupe de Recherche sur l'alcool et les pharmacodépendances - UMR INSERM_S 1247 UPJV GRAP; CHU Amiens-Picardie; Université Paul-Valéry - Montpellier 3 UPVM; Sciences Cognitives et Sciences Affectives (SCALab) - UMR 9193; Université de Reims Champagne-Ardenne URCA; Université de Montpellier UM
Publisher Information: Wiley
Publication Year: 2025
Collection: LillOA (Lille Open Archive - Université de Lille)
Subject Terms: binge drinking; digital intervention; e‐health; mobile application; phosphatidylethanol
Description: Objective The purpose of this paper is to describe a study protocol of a clinical trial exploring the effectiveness of the new mobile application MyDéfi proposing personalized feedback, on both alcohol consumption and quality of life, as well as the blood alcohol exposure biomarker phosphatidylethanol, in university students displaying binge drinking behavior. Methods This prospective national multicentric randomized, two‐arm (1:1), double‐blind controlled trial will recruit 628 students (aged 18–25 years) with binge drinking behavior. Participants will be randomized in the “intervention” group (personalized feedback) or the “control” group (generic feedback) and will undergo four monthly visits. Monthly dried blood spot sample for measuring phosphatidylethanol concentration and online questionnaires will be collected. Our primary objective is to assess the reduction weekly standard drinks, through self‐report gathered via MyDéfi. Secondary objectives will evaluate the application's impact on the dosage of phosphatidylethanol blood concentration and on quality of life”. Results Recruitment started in March 2024 and will end in March 2026. Conclusion This study aims to determine the effectiveness of two versions of the same mobile application (generic vs. personalized feedback) on alcohol consumption in students displaying binge drinking behavior. The effectiveness of the application will be measured, with a secondary objective of quantifying phosphatidylethanol. Our study will open new perspectives on the use of digital interventions for students who do not actively seek treatment. Trial Registration Trial registration number (NCT06084832), the date of registration (10th October 2023) and when this was done (16th October 2023). https://clinicaltrials.gov/study/NCT06084832 ; 34;2
Document Type: article in journal/newspaper
File Description: application/rdf+xml; charset=utf-8; application/octet-stream
Language: English
Relation: International Journal of Methods in Psychiatric Research; Int J Methods Psych Res
Availability: https://lilloa.univ-lille.fr/handle/20.500.12210/131965; https://hdl.handle.net/20.500.12210/131965
Rights: Attribution 3.0 United States ; info:eu-repo/semantics/openAccess
Accession Number: edsbas.72A95F54
Database: BASE